Distinct antigen recognition pattern during zoonotic visceral leishmaniasis in humans and dogs

Veterinary Parasitology

Volumn 160, Issue 3-4, 2009, Pages 215-220

  Goto, Yasuyuki ^a   Howard, Randall F ^a   Bhatia, Ajay ^a   Trigo, Joelma ^b   Nakatani, Maria ^c   Netto, Eduardo M ^c   Reed, Steven G ^a  

^a INFECTIOUS DISEASE RESEARCH INSTITUTE   (United States)

^b Canil Avançado em Monte Gordo de Pesquisa em Leishmanioses   (Brazil)

^c FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

Antigen; Dog; Leishmania infantum; Zoonosis

Indexed keywords

ANTIBODY RESPONSE; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LEISHMANIA INFANTUM; NONHUMAN; SERODIAGNOSIS; VISCERAL LEISHMANIASIS;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; BRAZIL; DISEASE OUTBREAKS; DISEASE RESERVOIRS; DOG DISEASES; DOGS; ENDEMIC DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; MALE; SEVERITY OF ILLNESS INDEX; ZOONOSES;

CANIS FAMILIARIS; LEISHMANIA INFANTUM;

EID: 60849092883     PISSN: 03044017     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetpar.2008.10.097     Document Type: Article

References (36)

1. Alexander J., Coombs G.H., and Mottram J.C. Leishmania mexicana cysteine proteinase-deficient mutants have attenuated virulence for mice and potentiate a Th1 response. J. Immunol. 161 (1998) 6794-6801
2. Badaro R., Benson D., Eulalio M.C., Freire M., Cunha S., Netto E.M., Pedral-Sampaio D., Madureira C., Burns J.M., Houghton R.L., David J.R., and Reed S.G. rK39: a cloned antigen of Leishmania chagasi that predicts active visceral leishmaniasis. J. Infect. Dis. 173 (1996) 758-761
3. Baneth G., and Shaw S.E. Chemotherapy of canine leishmaniosis. Vet. Parasitol. 106 (2002) 315-324
4. Barbieri C.L. Immunology of canine leishmaniasis. Parasite Immunol. 28 (2006) 329-337
5. Basu R., Bhaumik S., Basu J.M., Naskar K., De T., and Roy S. Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and -resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generation: evidence for mixed Th1- and Th2-like responses in visceral leishmaniasis. J. Immunol. 174 (2005) 7160-7171
6. Berberich C., Requena J.M., and Alonso C. Cloning of genes and expression and antigenicity analysis of the Leishmania infantum KMP-11 protein. Exp. Parasitol. 85 (1997) 105-108
7. Bhatia A., Daifalla N.S., Jen S., Badaro R., Reed S.G., and Skeiky Y.A. Cloning, characterization and serological evaluation of K9 and K26: two related hydrophilic antigens of Leishmania chagasi. Mol. Biochem. Parasitol. 102 (1999) 249-261
8. Burns Jr. J.M., Shreffler W.G., Benson D.R., Ghalib H.W., Badaro R., and Reed S.G. Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 775-779
9. Campos-Neto A., Porrozzi R., Greeson K., Coler R.N., Webb J.R., Seiky Y.A., Reed S.G., and Grimaldi Jr. G. Protection against cutaneous leishmaniasis induced by recombinant antigens in murine and nonhuman primate models of the human disease. Infect. Immun. 69 (2001) 4103-4108
10. Chappuis F., Sundar S., Hailu A., Ghalib H., Rijal S., Peeling R.W., Alvar J., and Boelaert M. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?. Nat. Rev. Microbiol. 5 (2007) 873-882
11. Dantas-Torres F. Leishmune vaccine: the newest tool for prevention and control of canine visceral leishmaniosis and its potential as a transmission-blocking vaccine. Vet. Parasitol. 141 (2006) 1-8
12. Dantas-Torres F. The role of dogs as reservoirs of Leishmania parasites, with emphasis on Leishmania (Leishmania) infantum and Leishmania (Viannia) braziliensis. Vet. Parasitol. 149 (2007) 139-146
13. Gavgani A.S., Hodjati M.H., Mohite H., and Davies C.R. Effect of insecticide-impregnated dog collars on incidence of zoonotic visceral leishmaniasis in Iranian children: a matched-cluster randomised trial. Lancet 360 (2002) 374-379
14. Ghedin E., Zhang W.W., Charest H., Sundar S., Kenney R.T., and Matlashewski G. Antibody response against a Leishmania donovani amastigote-stage-specific protein in patients with visceral leishmaniasis. Clin. Diagn. Lab. Immunol. 4 (1997) 530-535
15. Ghosh A., Zhang W.W., and Matlashewski G. Immunization with A2 protein results in a mixed Th1/Th2 and a humoral response which protects mice against Leishmania donovani infections. Vaccine 20 (2001) 59-66
16. Gomes Y.M., Paiva-Cavalcanti M., Lira R.A., Abath F.G., and Alves L.C. Diagnosis of canine visceral leishmaniasis: biotechnological advances. Vet. J. 175 (2008) 45-52
17. Goto Y., Bogatzki L.Y., Bertholet S., Coler R.N., and Reed S.G. Protective immunization against visceral leishmaniasis using Leishmania sterol 24-c-methyltransferase formulated in adjuvant. Vaccine 25 (2007) 7450-7458
18. Gramiccia M., and Gradoni L. The current status of zoonotic leishmaniases and approaches to disease control. Int. J. Parasitol. 35 (2005) 1169-1180
19. Herwaldt B.L. Leishmaniasis. Lancet 354 (1999) 1191-1199
20. Lukes J., Mauricio I.L., Schonian G., Dujardin J.C., Soteriadou K., Dedet J.P., Kuhls K., Tintaya K.W., Jirku M., Chocholova E., Haralambous C., Pratlong F., Obornik M., Horak A., Ayala F.J., and Miles M.A. Evolutionary and geographical history of the Leishmania donovani complex with a revision of current taxonomy. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 9375-9380
21. Moreno J., and Alvar J. Canine leishmaniasis: epidemiological risk and the experimental model. Trends Parasitol. 18 (2002) 399-405
22. Nakhaee A., Taheri T., Taghikhani M., Mohebali M., Salmanian A.H., Fasel N., and Rafati S. Humoral and cellular immune responses against Type I cysteine proteinase of Leishmania infantum are higher in asymptomatic than symptomatic dogs selected from a naturally infected population. Vet. Parasitol. 119 (2004) 107-123
23. Nylen S., and Sacks D. Interleukin-10 and the pathogenesis of human visceral leishmaniasis. Trends Immunol. 28 (2007) 378-384
24. Porrozzi R., Santos da Costa M.V., Teva A., Falqueto A., Ferreira A.L., dos Santos C.D., Fernandes A.P., Gazzinelli R.T., Campos-Neto A., and Grimaldi Jr. G. Comparative evaluation of enzyme-linked immunosorbent assays based on crude and recombinant leishmanial antigens for serodiagnosis of symptomatic and asymptomatic Leishmania infantum visceral infections in dogs. Clin. Vaccine Immunol. 14 (2007) 544-548
25. Pratlong F., Rioux J.A., Marty P., Faraut-Gambarelli F., Dereure J., Lanotte G., and Dedet J.P. Isoenzymatic analysis of 712 strains of Leishmania infantum in the south of France and relationship of enzymatic polymorphism to clinical and epidemiological features. J. Clin. Microbiol. 42 (2004) 4077-4082
26. Quinnell R.J., Courtenay O., Shaw M.A., Day M.J., Garcez L.M., Dye C., and Kaye P.M. Tissue cytokine responses in canine visceral leishmaniasis. J. Infect. Dis. 183 (2001) 1421-1424
27. Rafati S., Nakhaee A., Taheri T., Ghashghaii A., Salmanian A.H., Jimenez M., Mohebali M., Masina S., and Fasel N. Expression of cysteine proteinase type I and II of Leishmania infantum and their recognition by sera during canine and human visceral leishmaniasis. Exp. Parasitol. 103 (2003) 143-151
28. Rafati S., Zahedifard F., and Nazgouee F. Prime-boost vaccination using cysteine proteinases type I and II of Leishmania infantum confers protective immunity in murine visceral leishmaniasis. Vaccine 24 (2006) 2169-2175
29. Reithinger R., and Davies C.R. Canine leishmaniasis: novel strategies for control. Trends Parasitol. 18 (2002) 289-290
30. Reithinger R., Quinnell R.J., Alexander B., and Davies C.R. Rapid detection of Leishmania infantum infection in dogs: comparative study using an immunochromatographic dipstick test, enzyme-linked immunosorbent assay, and PCR. J. Clin. Microbiol. 40 (2002) 2352-2356
31. Schallig H.D., Cardoso L., Hommers M., Kroon N., Belling G., Rodrigues M., Semiao-Santos S.J., and Vetter H. Development of a dipstick assay for detection of Leishmania-specific canine antibodies. J. Clin. Microbiol. 42 (2004) 193-197
32. Seimenis A., Morelli D., and Mantovani A. Zoonoses in the Mediterranean region. Ann Ist Super Sanita 42 (2006) 437-445
33. Stager S., Smith D.F., and Kaye P.M. Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis. J. Immunol. 165 (2000) 7064-7071
34. Webb J.R., Campos-Neto A., Ovendale P.J., Martin T.I., Stromberg E.J., Badaro R., and Reed S.G. Human and murine immune responses to a novel Leishmania major recombinant protein encoded by members of a multicopy gene family. Infect. Immun. 66 (1998) 3279-3289
35. Webb J.R., Kaufmann D., Campos-Neto A., and Reed S.G. Molecular cloning of a novel protein antigen of Leishmania major that elicits a potent immune response in experimental murine leishmaniasis. J. Immunol. 157 (1996) 5034-5041
36. Zhang W.W., and Matlashewski G. Loss of virulence in Leishmania donovani deficient in an amastigote-specific protein A2. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 8807-8811